Table 1.
Baseline Demographics of Patients With Major Depressive Disorder Receiving Adjunctive Aripiprazole or Placebo (safety sample)
| Demographic | Placebo (n = 366) | Aripiprazole (n = 371) |
| Age, mean ± SE, y | 44.3 ± 0.6 | 45.5 ± 0.6 |
| Male/female, n (%) | 125/241 (34/66) | 134/237 (36/64) |
| Race, n (%) | ||
| White | 332 (91) | 327 (88) |
| Black | 24 (7) | 29 (8) |
| Asian | 4 (1) | 8 (2) |
| Other | 6 (2) | 7 (2) |
| Ethnicity, n (%) | ||
| Hispanic or Latino | 31 (8) | 17 (5) |
| Not Hispanic or Latino | 335 (92) | 354 (95) |
| No. of adequate antidepressant trials, n (%)a | ||
| 1 | 245 (67) | 254 (68) |
| 2 | 96 (26) | 94 (25) |
| 3 | 24 (7) | 21 (6) |
| 4 | 0 | 1 (< 1) |
a
Data missing for 1 patient in each treatment group.